☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Relapsed Small Cell
PharmaMar and Jazz Receive the US FDA's Priority Review Acceptance of Lurbinectedin's NDA for Patients with Relapsed Small Cell Lu...
February 17, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.